Tactician par excellence Gautam Gambhir couldn't have envisaged a battle of brains with a more different kind of adversary ...

Conor McGregor recently made big news but outside the octagon.

In a report released yesterday, Jason Zemansky from Bank of America Securities maintained a Buy rating on Acumen Pharmaceuticals (ABOS – ...

Daniel O'Connell; Chief Executive Officer, Director; Acumen Pharmaceuticals Inc W. Matthew Zuga; Chief Financial Officer, Chief Business Officer; Acumen Pharmaceuticals Inc Eric Siemers; Chief Medical ...

AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, in May 2024Initiation of a Phase 1 study to support a subcutaneous dosing option of sabirnetug ...

Hank Greenberg Invests In Cleveland Indians In 1948, Hank Greenberg, one of baseball’s legendary power hitters, acquired a ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Acumen Pharmaceuticals (NASDAQ:ABOS) just reported results for the first ...

Acumen Pharmaceuticals has dosed the first patient in ALTITUDE-AD, a Phase II trial designed to evaluate the clinical ...

Acumen Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.00025, expectations were $-0.23. Operator: Good ...

KKR co-owner Shah Rukh Khan kissed Gautam Gambhir's forehead following the side's emphatic 8-wicket win over SRH in IPL 2024 ...

Sixteen high school students from across the province showcased their business acumen and personal finance prowess in the ...

May 14, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic that ...